+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

United Kingdom Cardiac Disease Market Outlook to 2033 - Cardiac Marker Tests

  • PDF Icon

    Report

  • 31 Pages
  • June 2025
  • Region: United Kingdom
  • GlobalData
  • ID: 6108344
The “United Kingdom Cardiac Disease Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United Kingdom Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Marker Tests

The United Kingdom Cardiac Disease Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Cardiac Disease Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Cardiac Disease is segmented as follows:

  • Cardiac Marker Tests

Reasons to Buy

The United Kingdom Cardiac Disease Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Disease Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Disease Market, United Kingdom
3.1 Cardiac Disease Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Cardiac Marker Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Cardiac Marker Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
3.4 Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United Kingdom, Cardiac Disease Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Siemens Healthineers AG
4.3.1 Company Overview
4.4 Danaher Corp
4.4.1 Company Overview
4.5 Quidelortho Corp
4.5.1 Company Overview
4.6 bioMerieux SA
4.6.1 Company Overview
5 Cardiac Disease Market Pipeline Products
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 EDX Medical Group Raises USD0.38 Million in Private Placement of Shares
7 Recent Developments
7.1 Corporate Communications
7.1.1 Sep 30, 2024: EDX Medical Group: Annual General Meeting Results
7.2 Financial Announcements
7.2.1 Sep 04, 2024: EDX Medical Group Releases Annual Report and Financial Statements for the Period Ending March 31, 2024
7.3 Other Significant Developments
7.3.1 Sep 20, 2024: Funding Supports Neuranics’ Groundbreaking AI Technology for Remote Heart Health Monitoring
7.4 Strategy And Business Planning
7.4.1 Sep 20, 2024: Funding Supports Neuranics’ Groundbreaking AI Technology for Remote Heart Health Monitoring
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
Table 4: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
Table 5: Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
Table 6: Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024
Table 7: Cardiac Disease Market Pipeline Products
Table 8: EDX Medical Group Raises USD0.38 Million in Private Placement of Shares
Table 9: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
Figure 4: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
Figure 5: Cardiac Disease Market, United Kingdom, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories